Private Equity Hub -- Visiogen Inc., an Irvine, Calif.-based developer of products for cataract and refractive patients, has raised $40 million in fifth-round funding. Novartis Venture Fund led the round, and was joined by Technology Partners and return backers Three Arch Partners, New Leaf Venture Partners, Prospect Venture Partners, CMEA Ventures and Foundation Medical Partners. The company had previously raised around $57 million since 2001.
